Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 45.10
-0.31 (-0.68%)
At close: Feb 13, 2026
Hinova Pharmaceuticals Revenue
Hinova Pharmaceuticals had revenue of 10.18M CNY in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 23.61M, up 21,414.67% year-over-year. In the year 2024, Hinova Pharmaceuticals had annual revenue of 366.84K.
Revenue (ttm)
23.61M
Revenue Growth
+21,414.67%
P/S Ratio
189.15
Revenue / Employee
135.68K
Employees
174
Market Cap
4.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 366.84K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.65M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Hefei Lifeon Pharmaceutical | 1.47B |
| Pulike Biological Engineering | 1.10B |
| Boji Medical Technology | 770.19M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Assure Tech (Hangzhou) | 462.72M |
| Innovita Biological Technology | 430.96M |
| Guanhao Biotech | 392.83M |